This trial is testing whether a drug called rapamycin can treat vitiligo. People will apply it to one side of their body and a placebo to the other to see if there's a difference. The study will also see if patients are happy with the treatment and if there are any side effects.
3 Primary · 1 Secondary · Reporting Duration: 6 months
20 Total Participants · 3 Treatment Groups
Primary Treatment: Rapamycin · Has Placebo Group · Phase 2
Age Any Age · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||66.7%|
|Medical University of South Carolina||100.0%|
|Did not meet criteria||33.3%|